Processa Pharmaceuticals to Present at Access to Giving Virtual Conference on July 14, 2021 at 10:30 a.m. ET
06 Luglio 2021 - 2:15PM
Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) announced today that
the company will present at Access to Giving Virtual Conference.
The presentation will be given by Processa’s Chief Executive
Officer, Dr. David Young.
Registration DetailsDate: Wednesday, July 14,
2021Time: 10:30 a.m. ET Link:
https://access-to-giving.events.issuerdirect.com/signup
To learn more about the event or to schedule a
one-on-one meeting with Processa management, please visit
https://www.accesstogiving.com/ or email james@haydenir.com.
About Access to Giving Virtual Conference
Access to Giving is a first-of-its-kind virtual
investor conference where companies from microcap all the way up to
megacap will have the opportunity to present their story and
conduct 1x1 meetings with qualified investors, for charity.
Investors will make donations to purchase a block of meetings to
meet with companies.
About Processa
Pharmaceuticals, Inc.
The mission of Processa has been to develop
products where existing clinical evidence of efficacy already
exists in unmet medical need conditions, medical conditions where
patients need treatment options that will improve survival and/or
quality of life. The Company has assembled a proven regulatory
science development team, management team, and Board of Directors.
The Processa development team has been involved with more than 30
drug approvals by the FDA (including drug products targeted to
orphan disease conditions) and 100 FDA meetings. For more
information, please visit http://www.processapharma.com.
For More Information:Michael
Floydmfloyd@processapharma.com (301) 651-4256
James CarbonaraHayden IR(646) 755-7412james@haydenir.com
Grafico Azioni Processa Pharmaceuticals (NASDAQ:PCSA)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Processa Pharmaceuticals (NASDAQ:PCSA)
Storico
Da Lug 2023 a Lug 2024